| Breakdown | TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 90.31B | 92.92B | 85.88B | 77.49B | 66.94B | 65.49B |
| Gross Profit | 83.50B | 84.86B | 82.72B | 74.35B | 65.07B | 62.30B |
| EBITDA | 23.75B | 25.00B | 23.22B | 22.42B | 20.79B | 15.77B |
| Net Income | 16.48B | 15.83B | 14.01B | 14.17B | 13.06B | 9.98B |
Balance Sheet | ||||||
| Total Assets | 5.09T | 5.03T | 4.81T | 4.55T | 4.60T | 4.41T |
| Cash, Cash Equivalents and Short-Term Investments | 0.00 | 509.25B | 462.73B | 371.14B | 537.96B | 520.14B |
| Total Debt | 170.07B | 165.47B | 165.24B | 103.82B | 483.34B | 225.82B |
| Total Liabilities | 4.80T | 4.75T | 4.53T | 4.30T | 4.35T | 4.16T |
| Stockholders Equity | 287.22B | 281.62B | 275.17B | 245.19B | 243.33B | 240.28B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | 42.36B | -36.73B | -203.16B | 46.16B | 224.84B |
| Operating Cash Flow | 0.00 | 43.98B | -34.91B | -201.41B | 47.91B | 228.26B |
| Investing Cash Flow | 0.00 | -201.24B | 27.57B | 37.48B | -27.44B | -42.81B |
| Financing Cash Flow | 0.00 | 204.29B | 196.92B | -2.56B | -2.38B | -1.39B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
73 Outperform | ¥657.22B | 7.04 | 9.13% | 2.79% | 20.96% | 22.58% | |
72 Outperform | ¥188.51B | 7.61 | 7.40% | 5.60% | 3.10% | 17.73% | |
69 Neutral | ¥750.56B | 10.93 | 7.97% | 3.48% | 6.65% | -4.35% | |
68 Neutral | ¥161.49B | 6.29 | ― | 2.84% | 9.68% | -21.05% | |
68 Neutral | $18.00B | 11.42 | 9.92% | 3.81% | 9.73% | 1.22% | |
67 Neutral | ¥185.85B | 9.94 | ― | 4.42% | 2.13% | -25.62% | |
56 Neutral | ¥221.05B | 6.81 | 13.08% | 1.25% | 15.37% | 26.00% |